CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations

Nannini, Paula Romina; Borge, Mercedes; Mikolaitis, Vanesa Carla; Abreu, Cecilia; Morande, Pablo Elías; Zanetti, Samanta Romina; Oppezzi, Pablo; Palacios, Fernanda; Ledesma, Ignacio; Bezares, Raimundo Fernando; Giordano, Mirta; Gamberale, Romina.
Eur J Haematol ; 87(1): 80-86, julio, 2011. ilus
Artículo en Inglés | URUCAN | ID: bcc-4312

Documentos relacionados

  1. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.
  2. CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
  3. Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma.
  4. CCR4-NOT differentially controls host versus virus poly(a)-tail length and regulates HCMV infection.
  5. Immunopathogenesis of lymphoma: focus on CCR4.
  6. Potential roles of the CCL17-CCR4 axis in immunopathogenesis of oral lichen planus.
  7. Basic and clinical evaluation of anti-CCR4 mAb in cancer immunotherapy.
  8. Affinity-coupled CCL22 promotes positive selection in germinal centres.
  9. FcεRI-activated basophils express CCR4, CCR8, CCR9, CCX-CKR and XCR1.
  10. Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma.